AUPH — Aurinia Pharmaceuticals Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1600620 ·
Last close
$15.40
Market Cap
$2.06B
52W High
$19.25
52W Low
$13.52
ADV30
899,112
Next earnings
2026-10-30
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 83,699,000 | 75,393,000 | 35,363,000 | 31,703,000 | 825,704,000 | 46,145,000 | 168,185,000 |
| Jun 2026 | 83,220,000 | 76,665,000 | 46,341,000 | 37,414,000 | 792,262,000 | 179,832,000 | 177,398,000 |
| Mar 2026 | 77,705,000 | 71,200,000 | 41,422,000 | 34,355,000 | 723,997,000 | 41,008,000 | 156,371,000 |
| Dec 2025 | 77,114,000 | 68,315,000 | 33,239,000 | 210,794,000 | 751,587,000 | 80,213,000 | 170,256,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$175,243,000
Investing CF
$12,841,000
Financing CF
$-61,254,000
CapEx
$-274,000
Dividends Paid
—
Buybacks
$-83,551,000
EPS Diluted TTM
$2.29
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$-577,599,000
Inventory
$45,151,000
Receivables
$41,138,000
ST Investments
$263,291,000
EBIT TTM
$164,469,000
Pretax Income TTM
$160,363,000
Interest Exp TTM
$4,106,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$321,737,984
EBITDA
$185,420,000
Free Cash Flow
$132,733,376
Enterprise Value
$1,802,860,672
Total Cash
$486,880,000
Total Debt
$58,663,000
Shares Out
133,998,660
Trailing EPS
$2.28
Book Value
$4.91
ROE
61.4%
ROA
15.3%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 283,055,000 | 106,561,000 | 287,202,000 | 751,587,000 | 170,256,000 | 581,331,000 | 135,658,000 |
| Dec 2024 | 235,133,000 | 18,419,000 | 5,752,000 | 550,645,000 | 173,167,000 | 377,478,000 | 44,388,000 |
| Dec 2023 | 175,513,000 | -91,691,000 | -78,020,000 | 548,062,000 | 170,108,000 | 377,954,000 | -33,461,000 |
| Dec 2022 | 134,030,000 | -111,470,000 | -108,180,000 | 470,860,000 | 65,425,000 | 405,435,000 | -79,529,000 |
TTM Snapshot
Revenues TTM
$311,507,000
NetIncome TTM
$314,114,000
OpCashFlow TTM
—
Assets (Latest)
$792,262,000
Forward EPS
$1.04
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $22.00 · spot: $15.13 · call volume: 760 · put volume: 451
Expected Move to 2027-01-15:
±$2.05
(13.55%) —
implied range
$13.08 –
$17.18
· ATM straddle on $15.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IMNM | Immunome Inc. | $2.03B | $17.18 | — |
| PVLA | PALVELLA THERAPEUTICS, INC. | $2.11B | $144.35 | — |
| BHVN | Biohaven Ltd. | $2.00B | $13.24 | — |
| PRGO | PERRIGO Co plc | $2.19B | $15.76 | — |
| HRMY | Harmony Biosciences Holdings, Inc. | $1.94B | $33.01 | — |
News headlines (Yahoo Finance, 1h cache)
Earnings Beat May Change The Case For Aurinia Pharmaceuticals Stock
2026-11-06 10:15 · Yahoo
Aurinia Pharmaceuticals (AUPH) Tops Q3 Earnings Estimates
2026-10-30 12:05 · Yahoo
Aurinia: Q3 Earnings Snapshot
2026-10-30 12:04 · Yahoo
Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2026 and Provides Update on Recent Business Progress
2026-10-30 12:00 · Yahoo
Earnings Preview: Aurinia Pharmaceuticals (AUPH) Q3 Earnings Expected to Decline
2026-10-27 13:00 · Yahoo
How Investors Are Reacting To Aurinia Pharmaceuticals (AUPH) Extended Voclosporin Exclusivity And Share Buyback
2026-08-20 07:11 · Yahoo
Is Aurinia Pharmaceuticals Inc. (AUPH) A Good Stock To Buy Now?
2026-06-29 20:07 · Yahoo
AUPH Stock Rallies 6% After-Hours — Here’s Why
2026-08-19 22:15 · Yahoo
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis
2026-07-06 12:00 · Yahoo
Earnings Preview: Ionis Pharmaceuticals (IONS) Q3 Earnings Expected to Decline
2026-10-28 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.